# US 2023/0405294 A1 · Medical Tube and Method of Formation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0405294 A1
- Document ID: US20230405294A1
- Status: Published application
- Kind: A1
- Application number: 18/210,697
- Filed: 2023-06-16
- Published: 2023-12-21
- Earliest claimed: 2022-06-17
- Assignees: Tekni-Plex, Inc.
- Applicants: Tekni-Plex, Inc.
- Inventors: Paul McShane; Ian Kenny; Robin Van Landeghem
- Web page: https://patentgrep.com/patent/US20230405294A1

## CPC

- A61L 29/126: {having a macromolecular matrix}
- A61M 39/08: Tubes; Storage means specially adapted therefor
- A61L 29/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 29/085: {Macromolecular materials}
- A61L 29/14: Materials characterised by their function or physical properties {, e.g. lubricating compositions}
- B32B 1/08: Tubular products
- B32B 27/08: of synthetic resin
- B32B 27/306: {comprising vinyl acetate or vinyl alcohol (co)polymers}
- B32B 27/32: comprising polyolefins {(comprising vinyl (co)polymers or acrylic (co)polymers B32B27/30)}
- B32B 27/40: comprising polyurethanes
- F16L 11/04: made of rubber or flexible plastics
- A61M 25/0045: {multi-layered, e.g. coated (coating materials A61L29/08)}
- A61M 2207/00: Methods of manufacture, assembly or production
- B32B 2250/03: 3 layers
- B32B 2250/24: All layers being polymeric
- B32B 2307/412: Transparent
- B32B 2307/7376: Thickness
- B32B 2535/00: Medical equipment, e.g. bandage, prostheses or catheter
- B32B 2597/00: Tubular articles, e.g. hoses, pipes
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B32B: LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- F16L: PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL

## Abstract

In one embodiment, a visually clear or transparent and manually flexible medical tube (10) adapted for in vivo transport of an aqueous fluid to a subject comprising an inner layer (3), a middle layer (2) and an outer layer (1), wherein the inner layer (3) comprises a polypropylene, the outer layer (1) comprises a thermoplastic polyurethane or a cyclic olefin copolymer, and the middle layer (2) is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

## Claims

### Claim 1

A tube (10) adapted for in vivo transport of an aqueous fluid to a subject comprising an inner layer (3), a middle layer (2) and an outer layer (1),
wherein the tube is formed by a co-extrusion process, the inner layer (3), middle layer (2) and outer layer (1) are concentric and the inner layer (3) and outer layer (1) are adhered to the middle layer (2) and thus adhered to each other, wherein
the inner layer (3) comprises a polypropylene,
the outer layer (1) comprises a thermoplastic polyurethane and
the middle layer (2) is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

### Claim 2 (depends on 1)

The tube of claim 1 wherein the middle layer (2) comprises an ethylene ethyl acrylate copolymer or an ethylene methyl acrylate copolymer or an anhydride grafted ethylene methyl acrylate copolymer, a copolymer of two or more of said acrylates or a mixture of two or more of the foregoing.

### Claim 3 (depends on 1)

The tube of claim 1 wherein the middle layer (2) comprises ethylene vinyl acetate.

### Claim 4 (depends on 1)

The tube (10) of claim 1 wherein the inner layer (3) comprises more than 90% by weight of a polypropylene homopolymer or a polypropylene copolymer, the outer layer (1) comprises more than 90% by weight of an aromatic or aliphatic polyether based polyurethane and the middle layer (2) comprises more than 90% by weight of the one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

### Claim 5 (depends on 4)

The tube of claim 4 wherein the middle layer (2) comprises ethylene ethyl acrylate copolymer with at least 19.5 percent ethyl acrylate content by weight.

### Claim 6 (depends on 4)

The tube of claim 4 wherein the middle layer (2) comprises more than 90% by weight of the ethylene methyl acrylate copolymer.

### Claim 7 (depends on 4)

The tube of claim 4 wherein the middle layer (2) comprises ethylene vinyl acetate with at least 19.5 percent vinyl acetate content by weight.

### Claim 8 (depends on 1)

The tube of claim 1 wherein the inner layer (3) comprises more than 90% by weight of a polypropylene homopolymer or a polypropylene copolymer or a mixture of the homopolymer and copolymer, the outer layer (1) comprises more than 90% by weight of a polytetramethyleneglycol-based polyurethane.

### Claim 9 (depends on 1)

The tube of claim 1 wherein the thickness of the polyurethane outer layer is between 0.0254 and 0.635 mm (0.001 and 0.025 inches) the thickness of the inner polypropylene layer is between 0.0254 and 0.635 mm (0.001 and 0.025 inches) and the thickness of the middle layer is between 0.0254 and 0.635 mm (0.001 and 0.025 inches).

### Claim 10 (depends on 1)

The tube of claim 1 wherein the inner (3) and outer (1) layers do not visually delaminate from the middle layer (2) at a stress up to 20 MPa and a strain up to 400%.

### Claim 11 (depends on 1)

The tube of claim 1 wherein the tube (10) does not visually delaminate when submersed in water at 60° C. for 72 hours.

### Claim 12 (depends on 1)

The tube of claim 1 wherein the tube (10) has a central axial fluid flow passage through which aqueous fluid is routed, the inner layer (3) having a radially inner wall surface that contacts the aqueous fluid the outer (1) and inner (3) layers resisting delamination from the middle layer (2) at a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being submersed in water at 60° C. for 72 hours.

### Claim 13 (depends on 1)

The tube of claim 1 wherein the inner (3) and outer (1) layers do not visually delaminate from the middle layer (2) at a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being submersed in water at 60° C. for 72 hours.

### Claim 14 (depends on 1)

The tube of claim 1 wherein the outer layer (1) comprises more than 90% by weight of an aromatic polyether-based polyurethane, and
wherein the tube does not visually delaminate after being submersed in water at 60° C. for 72 hours.

### Claim 15 (depends on 1)

A method of delivering an aqueous fluid in vivo comprising:
selecting one or more aqueous compositions that are efficacious for treatment of a condition of a subject, the aqueous compositions being selected from the group of aqueous drug suspensions, aqueous compositions that include a chemotherapy drug and aqueous compositions that include insulin,
delivering one or more of the selected aqueous compositions through a tube to the subject via flow through a tube according to claim 1.

### Claim 16

A method of forming a visually clear or transparent and manually flexible medical tube for in vivo transport of an aqueous fluid, the method of forming comprising:
selecting a first polymeric material that is an aromatic or aliphatic polyether based polyurethane material having a selected structural stability; and
selecting a second polymeric material that is a polypropylene material that is inert to aqueous fluids;
selecting a third polymeric material that is elastomeric in nature and has visual clarity and is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene
co-extruding the selected first, second and third polymeric materials to form respectively adhered outer, inner and middle layers of the medical tube in a configuration such that the outer layer comprises at least 90% by weight of the first polymeric material, the inner layer comprises at least 90% weight of the second polymeric material and the middle layer comprises at least 90% by weight of the third polymeric material,
the materials being selected so as to maintain the integrity of the tube against delamination and maintain its visual clarity or transparency after being subjected to one or more of ethylene oxide and gamma irradiation sterilization,
wherein the medical tube has a central axial fluid flow passage defined by a radial inner wall surface of the inner layer through which aqueous fluid is transported, and wherein the tube does not visually delaminate after being submersed in water at 60 degrees C. for 72 hours and subsequently mechanically flattened by manual squeezing of the tube from its normal round in cross-sectional condition to a flattened or oval cross-sectional shape or condition.

### Claim 17

A tube (10) adapted for in vivo transport of an aqueous fluid to a subject comprising an inner layer (3), a middle layer (2) and an outer layer (1),
wherein the tube is formed by a co-extrusion process, the inner layer (3), middle layer (2) and outer layer (1) are concentric and the inner layer (3) and outer layer (1) are adhered to the middle layer (2) and thus adhered to each other, wherein
the inner layer (3) comprises a polypropylene,
the outer layer (1) comprises a cyclic olefin copolymer and
the middle layer (2) is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

### Claim 18 (depends on 17)

The tube (10) of claim 17 wherein the inner layer (3) comprises more than 90% by weight of a polypropylene homopolymer or a polypropylene copolymer, the outer layer (1) comprises more than 90% by weight of a cyclic olefin copolymer and the middle layer (2) comprises more than 90% by weight of the one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

### Claim 19 (depends on 17)

The tube of claim 17 wherein the inner (3) and outer (1) layers do not visually delaminate from the middle layer (2) at a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being submersed in water at 60° C. for 72 hours.

### Claim 20 (depends on 17)

A method of delivering an aqueous fluid in vivo comprising:
selecting one or more aqueous compositions that are efficacious for treatment of a condition of a subject, the aqueous compositions being selected from the group of aqueous drug suspensions, aqueous compositions that include a chemotherapy drug and aqueous compositions that include insulin,
delivering one or more of the selected aqueous compositions through a tube to the subject via flow through a tube according to claim 17.

### Claim 21

A method of forming a visually clear or transparent and manually flexible medical tube for in vivo transport of an aqueous fluid, the method of forming comprising:
selecting a first polymeric material that is an aromatic or aliphatic polyether based polyurethane material having a selected structural stability; and
selecting a second polymeric material that is a polypropylene material that is inert to aqueous fluids;
selecting a third polymeric material comprising an acrylate copolymer that is elastomeric in nature and has visual clarity and is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene
co-extruding the selected first, second and third polymeric materials to form respectively adhered outer, inner and middle layers of the medical tube in a configuration such that the outer layer comprises at least 90% by weight of the first polymeric material, the inner layer comprises at least 90% weight of the second polymeric material and the middle layer comprises at least 90% by weight of the third polymeric material,
the materials being selected so as to maintain the integrity of the tube against delamination and maintain its visual clarity or transparency after being subjected to one or more of ethylene oxide and gamma irradiation sterilization,
wherein the medical tube has a central axial fluid flow passage defined by a radial inner wall surface of the inner layer through which aqueous fluid is transported, and wherein the tube does not visually delaminate after being submersed in water at 60 degrees C. for 72 hours and subsequently mechanically flattened by manual squeezing of the tube from its normal round in cross-sectional condition to a flattened or oval cross-sectional shape or condition.
